The meeting of the American Society of Oncology shows in Chicago the two faces of the disease. One of the big questions that in 2023 science is still trying to answer is when cancer can stop being that word that, when pronounced, leads to think about death.
There is a red light on at ASCO in that sense, which underlies the 2,900 scientific works – a record – that show these days the new therapeutic trends for different types of cancer. Authorities issued new clinical guidance to better treat patients with gastrointestinal cancer amid shortages of cisplatin and carboplatin.